首页> 外国专利> CORRELATION BETWEEN HUMORAL IMMUNE RESPONSE TO TUMOR ANTIGEN FOLLOWING TREATMENT WITH CANCER ANTIGEN-SPECIFIC ACTIVE IMMUNOTHERAPY, AND IMPROVED CLINICAL OUTCOME THEREOF

CORRELATION BETWEEN HUMORAL IMMUNE RESPONSE TO TUMOR ANTIGEN FOLLOWING TREATMENT WITH CANCER ANTIGEN-SPECIFIC ACTIVE IMMUNOTHERAPY, AND IMPROVED CLINICAL OUTCOME THEREOF

机译:癌抗原特异性主动免疫治疗对肿瘤抗原的免疫应答与临床疗效的相关性

摘要

To provide a system, a method and a composition for predicting a treatment result of a patient under cancer immunotherapy, and for measuring antigen proliferation to identify a prospective target for the cancer immunotherapy.SOLUTION: A cancer patient's response is predicted with respect to cell antigen-specific active immunotherapy (CASAI), by measuring a reactive reference antibody level against one or plural predetermined non-target biomarker antigens.SELECTED DRAWING: Figure 1
机译:为了提供一种系统,方法和组合物,用于预测在癌症免疫疗法下的患者的治疗结果,并用于测量抗原增殖以鉴定癌症免疫疗法的预期靶标。解决方案:预测癌症患者对细胞抗原的反应特异性主动免疫疗法(CASAI),方法是测量针对一种或多种预定的非靶标生物标志物抗原的反应性参考抗体水平。图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号